PS
EW icon

Principal Securities’s Edwards Lifesciences EW Stock Holding History

Principal Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
13,293
+7,291
+121% +$611K 0.01% 719
2026
Q1 		$481K Buy
6,002
+1,188
+25% +$97.9K 0.01% 996
2025
Q4 		$410K Buy
4,814
+1,184
+33% +$97.2K 0.01% 1012
2025
Q3 		$282K Buy
3,630
+1,991
+121% +$156K ﹤0.01% 1139
2025
Q2 		$128K Sell
1,639
-997
-38% -$74.4K ﹤0.01% 1434
2025
Q1 		$195K Hold
2,636
– – ﹤0.01% 1147
2024
Q4 		$195K Sell
2,636
-1,281
-33% -$89.7K ﹤0.01% 1147
2024
Q3 		$258K Sell
3,917
-2,850
-42% -$207K 0.01% 1001
2024
Q2 		$625K Buy
6,767
+481
+8% +$42.6K 0.02% 627
2024
Q1 		$601K Sell
6,286
-253
-4% -$21.3K 0.02% 599
2023
Q4 		$499K Buy
+6,539
New +$455K 0.02% 603

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Principal Securities's EW Position: Q2 2026 in Review

Principal Securities increased its Edwards Lifesciences (EW) stake by 121% in Q2 2026, buying an estimated $611K and bringing the position to 13,293 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #719.

Principal Securities first reported a position in EW in Q4 2023 and has held it in 11 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Principal Securities held 13,293 shares of Edwards Lifesciences worth $1.2M as of Q2 2026.
  • Principal Securities bought 7,291 Edwards Lifesciences shares in Q2 2026, an estimated $611K.
  • Edwards Lifesciences made up 0.01% of Principal Securities's portfolio in Q2 2026, its #719 holding.
  • Principal Securities first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.